COL6A1 , LAPTM5 , and ZFAND2A as Crucial Biomolecules Driving Immunoregulation in Human Nucleus Pulposus Degeneration
The FASEB Journal · 2025
DOI: 10.1096/fj.202500320r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Ze-Yu Lu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Spine Center, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Intervertebral Disc Degeneration, Nucleus Pulposus, Collagen Type VI, Membrane Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Shanghai Municipal Health Commission (), MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Intervertebral disc degeneration (IVDD) is a major contributor to chronic low back pain, driven by complex interactions among immune cells and various molecular mechanisms. In this study, we integrated single‐cell RNA sequencing (scRNA‐Seq), transcriptomics, and Mendelian randomization (MR) analysis to investigate the immune mechanisms and identify key biomolecules involved in IVDD. Single‐cell analysis of nucleus pulposus (NP) samples from four patients with disc degeneration revealed 20 distinct clusters, which were categorized into four primary cell types: blood cells, chondrocytes, endothelial cells, and stromal cells. These cell types were shown to play crucial roles in the immune microenvironment, as evidenced by ligand‐receptor interaction analysis, which delineated potential intercellular communication networks. By combining eQTL (expression Quantitative Trait Loci) data with FinnGen datasets in MR analysis, we identified five key genes (CD83, COL6A1, LAPTM5, NPC2, ZFAND2A) significantly associated with IVDD risk. The expression of these genes in NP tissues showed strong correlations with immune cell infiltration. Protein‐level validation confirmed the upregulation of COL6A1, LAPTM5, and ZFAND2A in degenerative NP tissues. Functional enrichment analysis revealed their involvement in multiple immune‐related pathways. Additionally, co‐expression analysis identified relationships between these key genes and critical immune genes, such as CD14 and CD274. This study leverages multi‐omics integration to uncover the immune regulatory mechanisms underlying IVDD, providing valuable insights into the role of biomolecules in the pathogenesis of disc degeneration and offering potential for novel diagnostic and therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Spine Center, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Medical Technology, School of Exercise and Health, Shanghai University of Sport, Shanghai, China.
ORCID-Profile: Ze-Yu Lu, Peng-Bo Chen, Qing-Yin Xu, Muradil Mardan, Meng-Jia You, Bo Li, Sheng-Dan Jiang, Lei-Sheng Jiang, Xin-Feng Zheng
Förderung
- Shanghai Municipal Health Commission ()
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Lu, Z. Y., Chen, P. B., Xu, Q. Y., Mardan, M., You, M. J., Li, B., Jiang, S. D., Jiang, L. S., & Zheng, X. F. (2025). COL6A1 , LAPTM5 , and ZFAND2A as Crucial Biomolecules Driving Immunoregulation in Human Nucleus Pulposus Degeneration. The FASEB Journal. https://doi.org/10.1096/fj.202500320r
Vancouver
Lu ZY, Chen PB, Xu QY, Mardan M, You MJ, Li B, et al. COL6A1 , LAPTM5 , and ZFAND2A as Crucial Biomolecules Driving Immunoregulation in Human Nucleus Pulposus Degeneration. The FASEB Journal. 2025. doi:10.1096/fj.202500320r
BibTeX
@article{Lu2025,
author = {Lu, Ze-Yu and Chen, Peng-Bo and Xu, Qing-Yin and Mardan, Muradil and You, Meng-Jia and Li, Bo and Jiang, Sheng-Dan and Jiang, Lei-Sheng and Zheng, Xin-Feng},
title = {COL6A1 , LAPTM5 , and ZFAND2A as Crucial Biomolecules Driving Immunoregulation in Human Nucleus Pulposus Degeneration},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202500320r}
}
EUVIMED